Tesamorelin – Research Peptide
Tesamorelin is a synthetic analogue of endogenous growth hormone-releasing hormone (GHRH), engineered with a trans-3-hexenoic acid modification at its N-terminus to enhance stability and potency. It targets GHRH receptors in the anterior pituitary to stimulate downstream GH and IGF-1 production.
Research Context
Tesamorelin’s clinical research has been focused predominantly on visceral adipose tissue (VAT) reduction, making it a primary research tool in models of lipodystrophy and fat distribution. Published data also supports its role in body composition, bone density, and GH-mediated metabolic outcomes.
Properties
- Class: GHRH analogue
- Form: Lyophilized powder
- Purity: ≥98% (HPLC verified)
- Quantity: 20mg per vial
Storage & Handling
Store at -20°C for long-term stability. Reconstitute with sterile bacteriostatic water. Refrigerate at 2–8°C after reconstitution.
Disclaimer: This product is strictly intended for in vitro laboratory research purposes only. Not for human or veterinary use.
